Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents
This study is currently recruiting participants.
Study NCT00418977   Information provided by National Institute of Mental Health (NIMH)
First Received: January 3, 2007   Last Updated: March 16, 2009   History of Changes

January 3, 2007
March 16, 2009
September 2005
August 2010   (final data collection date for primary outcome measure)
Diagnostic criteria of anorexia nervosa [ Time Frame: Measured at pre-treatment, post-treatment, and 6 and 12 months post-treatment ] [ Designated as safety issue: No ]
Diagnostic criteria of anorexia nervosa
Complete list of historical versions of study NCT00418977 on ClinicalTrials.gov Archive Site
 
 
 
Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents
Early Identification and Treatment of Anorexia Nervosa

This study will compare the effectiveness of two therapies to treat early signs of anorexia nervosa in adolescents.

Eating disorders often result in serious illness and can lead to prolonged health complications, including heart and kidney problems, digestive disorders, nerve damage, and low blood pressure. Anorexia nervosa is a type of eating disorder in which a person does not eat enough for fear of becoming overweight, resulting in extreme weight loss. Women are at a greater risk of developing this disease, particularly when they are between the ages of 12 and 24. Treatments for anorexia nervosa typically include nutrition counseling, psychotherapy, and medication. The purpose of this study is to compare the effectiveness of two therapies to treat adolescents who have signs of anorexia nervosa but have not fully developed the disease.

Potential participants will attend 2 screening visits during which parents and children will complete separate questionnaires and undergo 3 interviews regarding eating behaviors and changes in mood. Once screening evaluations have been completed, eligible participants will be randomly assigned to 1 of 2 treatment groups. Participants assigned to the first group will receive 14 family therapy sessions. All family members living with the child will be asked to attend these sessions with the child. Family members will learn strategies to help the child eat enough at home and will address various issues concerning family relationships. Children will learn how to eat well on their own and will also discuss topics related to family dynamics. Participants assigned to the second group will receive 14 individual therapy sessions that will focus on the child and not include family members. Before each treatment session, parents will speak with the therapist to discuss progress and any new concerns or issues regarding the child's condition. The therapist will then work directly with the child to discuss what may be causing the child's signs of anorexia nervosa and how to handle difficult emotions associated with the disorder. Participants in both treatment groups will attend 1-hour therapy sessions that will occur weekly for 8 sessions, then biweekly for 4 sessions, and monthly for the last 2 sessions. Evaluations, lasting 3 to 4 hours, will occur before treatment begins, immediately following treatment, and 6 and 12 months post-treatment. Evaluations will consist of interviews and questionnaires used to assess whether treatment was effective in preventing participants from developing anorexia nervosa.

 
Interventional
Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Eating Disorders
  • Behavioral: Family-Based Therapy ("Maudsley Method")
  • Behavioral: Individual Supportive Psychotherapy
  • Experimental: Participants will receive family based therapy (FBT)
  • Active Comparator: Participants will receive individual supportive psychotherapy (ISP)
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
60
August 2010
August 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Living with family or guardian
  • Medically stable for outpatient treatment
  • Meets two to three criteria for anorexia nervosa
  • Receiving a stable dose of psychotropic medication (if applicable)

Exclusion Criteria:

  • Meets DSM-IV criteria for anorexia nervosa
  • Current psychotic illness, alcohol or drug dependence, or medical or physical conditions known to influence eating, weight, or menstrual status
  • Previous participation in study treatment
  • Unable to withdraw from current psychological treatment
Both
10 Years to 17 Years
No
Contact: Lauren Alfano lauren.alfano@mssm.edu
United States
 
NCT00418977
Dr. Katharine Loeb, PhD/Assistant Professor, Mount Sinai School of Medicine
K23 MH074506, DSIR 84-CTS
National Institute of Mental Health (NIMH)
 
Principal Investigator: Katharine Loeb, PhD Mount Sinai School of Medicine
National Institute of Mental Health (NIMH)
March 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP